首页> 美国卫生研究院文献>Influenza and Other Respiratory Viruses >Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014–2015 influenza season in Alberta Canada
【2h】

Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014–2015 influenza season in Alberta Canada

机译:2014-2015年加拿大艾伯塔省流感季节从免疫受损患者中分离出的甲型流感病毒(H3N2)的Oseltamivir耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This manuscript describes the identification of an oseltamivir‐resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014–2015 influenza season. Following treatment with oseltamivir, neuraminidase (NA) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA‐Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir‐resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.
机译:本手稿描述了在2014-2015年流感季节期间从加拿大艾伯塔省一名免疫受损患者收集的呼吸道标本中鉴定出耐奥司他韦的甲型H3N2流感病毒。用奥司他韦治疗后,神经氨酸酶(NA)基因测序表明存在R292K突变。通过NA-Star分析进行的表型药敏试验表明,奥司他韦的抑制作用大大降低,而扎那米韦的抑制作用则正常。在鉴定出耐奥司他韦的菌株后结合使用扎那米韦,并进行部分免疫重建,然后建议减少鼻咽中的鼻咽病毒载量并改善患者的临床状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号